Caremark was found liable in June, and Philadelphia federal court Chief Judge Mitchell Goldberg ordered the company to pay ...

Whistleblower Sarah Behnke's lawsuit leads to $290 million judgment against CVS Caremark for overcharging Medicare on prescription drugs in 2013 and 2014.

Chief Judge Mitchell Goldberg tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the ...

A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...

A Pennsylvania judge has ordered CVS to pay $289 million in damages as part of a long-running whistleblower case. | A ...

CVS Health (CVS) stock in focus as its pharmacy benefit manager CVS Caremark faces $289.9M in damages and penalties for ...

A federal judge has ordered CVS Caremark to pay almost $290 million in damages and penalties after a whistleblower proved the pharmacy benefit manager overcharged Medicare for prescription drugs.

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Joshua Fredell, Pharm.D., senior vice president at CVS Caremark, says innovation in PBMs comes from simplifying pricing, offering flexible benefit designs, and using technology to create a smoother ...

Helle emphasized that Caremark's work around equity so far is merely a starting point, and the industry can expect to see more to come from both the PBM and CVS Health broadly.

CVS Caremark originally entered into a corporate integrity agreement in 2008, when it paid $36.7 million to resolve allegations from a CVS pharmacist that the company improperly switched patients ...

CVS shares fell $2.32, or 7.4 percent, to close at $29.06 on the New York Stock Exchange while Caremark lost $1.06, or 2.2 percent, to finish at $48.17.